Acadian Asset Management
RETA

Acadian Asset Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Acadian Asset Management’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,159
Closed -$287K – 1957
2023
Q1 		$287K Buy
+3,159
New +$287K ﹤0.01% 1185